Whether you're in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.
Blog
Why AAV Gene Therapy Innovation Must Align with Manufacturing Readiness
Apr 13, 2026
Blog
FDA’s CGT Flexibilities: Clarity for Developers, Complexity for Strategy
Mar 20, 2026
Blog
Efficiency, Scale and the Role of Cohesive CMC and Manufacturing Planning
Dec 9, 2025
Blog
Developing iPSC Therapies: Why Your CMC Strategy Needs to Start Early
Jul 15, 2025